U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261631) titled 'Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors' on Nov. 21.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, dosimetry and preliminary efficacy of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients aged >= 18 years with solid tumors
Study Start Date: Nov. 24
Study Type: INTERVENTIONAL
Condition:
Pancreatic Ductal Adenocarcinoma
Non-Small Cell Lung Cancer
HR+/HER2- Ductal and Lobular Breast Cancer
Triple Negative Breast Cancer
Colorectal Cancer
Soft Tissue Sarcoma
Intervention:
DRUG: 68Ga-NNS309
Diagnostic investigational radiopharmaceutical
DRUG:...